Id-KLH

BIOLOGICAL2 trials

Sponsors

Favrille, University of Nebraska

Conditions

LymphomaNon-Hodgkin's Lymphoma

Phase 2

Rituxan Plus FavId (Idiotype Vaccine) for Low-grade Non-Hodgkin's Lymphoma

FavrilleNon-Hodgkin's Lymphoma

Start: 2002-07-31Target: 90Updated: 2009-09-30

Unknown Phase

Idiotype Vaccine After Chemotherapy & Stem Cell Transplantation in Lymphoma With Failed Induction Chemotherapy

CompletedNCT00574886

University of NebraskaLymphoma

Start: 2000-08-03End: 2008-04-15Updated: 2023-12-08